Log in or Sign up for Free to view tailored content for your specialty!
Genetics/Genomics News
Maternal inheritance of FH may increase odds of subclinical coronary calcium by midlife
Researchers in France observed that maternal inheritance of familial hypercholesterolemia was associated with greater odds of having subclinical coronary atherosclerosis compared with paternal inheritance of the gene mutation.
CAD polygenic risk score may guide statin initiation for younger adults
Biobank data suggest targeted polygenic risk score testing in younger adults with borderline or intermediate clinical risk may be a useful strategy for determining who will benefit most from initiating statin therapy, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
ACC announces late-breaking science lineup for 2023 Scientific Session
The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March 4-6, 2023 in New Orleans and online.
Walking 10K steps per day may slow aortic dilation in pediatric Marfan syndrome
A 6-month intervention with an exercise target of 10,000 steps per day may slow aortic root dilation in pediatric patients with Marfan syndrome, according to study data published in the Journal of the American Heart Association.
Spaceflight may be linked to somatic mutations, increased risk for cancer, heart disease
Spaceflight may place astronauts at increased risk for developing mutations that can lead to cancer and heart disease, according to a study published in Nature Communications Biology.
Fatty liver disease conditions ‘change the healthy heart to a failing heart’
CVD risk increases with the severity of nonalcoholic fatty liver disease, and both CV and liver events are “highly related” to the degree of hepatic fibrosis present, according to a speaker.
In FH, Lp(a) levels comparable to LDL in risk for premature poor outcomes
Lipoprotein(a) levels of 67 mg/dL or more may be indicative of similar risk for premature MI as LDL of 180 mg/dL or more in patients with familial hypercholesterolemia, researchers reported.
CRISPR-based genome editing therapy may help in ATTR amyloidosis with cardiomyopathy
CHICAGO — A novel CRISPR-based in vivo gene editing therapy reduced transthyretin levels in patients with hereditary transthyretin amyloidosis with cardiomyopathy, researchers reported at the American Heart Association Scientific Sessions.
Genetic variants linked to inherited cardiomyopathies; disease penetrance remains low
Cardiomyopathy and HF diagnosis were more common among individuals with certain pathogenic variants compared with those without; however, prevalence was low, between 1% and 3% overall, researchers reported.
Vaccination reduces risk for VTE among ambulatory patients with COVID-19
Individuals who acquired COVID-19 infection not requiring hospitalization had greatly increased risk for incident venous thromboembolism, according to results of an English population-based cohort study.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read